NCT06299670View on ClinicalTrials.gov

Efficacy of Combination of Hdroxyurea and Thalidomide Over Either Hydroxyurea or Thalidomide Alone in the Treatment of Transfusion Dependent Thalassemia in Children: A Quasi-Randomised Clinical Trial

PHASE4RecruitingINTERVENTIONAL
Enrollment

90

Participants

Timeline

Start Date

November 1, 2023

Primary Completion Date

June 30, 2024

Study Completion Date

December 31, 2024

Conditions
Transfusion-dependent Thalassemia
Interventions
DRUG

Thalidomide

Patients will get only Thalidomide

DRUG

Hydroxy Urea

Patients will get only Hydroxyurea

DRUG

Combinations

Combination Of Thalidomide \& Hydroxyurea

Trial Locations (1)

1000

RECRUITING

Bangabandhu Sheikh Mujib Medical University, Dhaka

All Listed Sponsors
lead

Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh

OTHER